P
ProQR Therapeutics NV D
D
PRQR
2.21000
USD
-0.02
(-0.67%)
مفتوح الان
حجم التداول
1,963
الربح لكل سهم
-0
العائد الربحي
-
P/E
-6
حجم السوق
232,807,948
الأخبار المقالات
العنوان: ProQR Therapeutics NV
القطاع: Healthcare
الصناعة: Biotechnology
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.